All News

Will FDA classify hydrocodone as Schedule III, Schedule II, or somewhere in between?

Guideline-directed medical therapy for heart failure (HF) is highly cost-effective and able to produce significant health gains for individuals with mild to moderate disease, according a study published April 2 in the Journal of the American College of Cardiology.

First new NVP approval in 50 years brings back 30-year-old drug

The antiarrhythmia drug amiodarone appears to be linked to a higher risk of cancer in men, specifically those who receive higher cumulative defined daily doses within the first year of treatment, according to a retrospective study published online April 8 in Cancer.

Ruling clears obstacles judge said were politically influenced

Pharmacists and other healthcare providers are still confusing Prilosec (omeprazole) and Prozac (fluoxetine) prescriptions, according to a new report from the Institute for Safe Medication Practices (ISMP).

The Academy of Managed Care Pharmacy has changed the foundation’s name to the Academy of Managed Care Pharmacy Foundation. In addition, it has elected four new members to its board of trustees, during the AMCP’s 25th annual meeting and exposition in San Diego.

The IMS report tracked impact of care on Managed Medicaid beneficiaries in Kentucky, New Jersey, New York, and Ohio since 2011 in three therapeutic areas: antipsychotics, diabetes agents, and respiratory medications

Restrictive state Medicaid policies are delaying care because of cost and should be reconsidered, according to a recent NEJM letter to the editor.

Walgreens announced April 2 that it is expanding its Balance Rewards program to give extra points to customers for completing health-related activities.

NCPA responds to CMS' final call letter for 2014 PDPs

First winners of the "Pharmacy Is Right for Me Student Innovation Challenge" are announced

A review of the literature provides moderate strength evidence that sublingual immunotherapy is effective for the treatment of allergic rhinitis and asthma, according to an article published March 27 in the JAMA.

The third edition of APhA's pocket reference is now available

Diabetes drug canagliflozin (Invokana, Janssen Pharmaceuticals) is the first drug approved by the FDA in a new class known as sodium-glucose co-transporter 2 (SGLT2) inhibitors.

The use of extended-release niacin as an adjunct to statins does not reduce the risk of a heart attack or stroke in patients with pre-existing cardiovascular disease, according to researchers who led the HPS2-THRIVE study.

Patrons of the Empire State building will now be able to stop in a new flagship Walgreens store that opened March 23.

The U.S. Supreme Court will have to decide whether reverse payments, also known as “pay-for-delay settlements,” between branded and generic drug companies are anticompetitive and violate U.S. antitrust law.

The third edition of "Peripheral Brain for the Pharmacist" is now available

Health Subcommittee members of the House Committee of Energy and Commerce listened Wednesday as a group of healthcare professionals weighed-in on potential regulations and taxes of medical mobile applications during the “Health Information Technologies” hearing.